Related Experiment Videos
[Reflex dystrophy affects children, too]
Steen W Henneberg1, Susan M Nielsen, Freddy Karup Pedersen
1H:S Rigshospitalet, Juliane Marie Centret, Anaestesi- og Operationsafdeling 4013/4014, og Paediatrisk Klinik II.
Ugeskrift for Laeger
|July 23, 2003
Summary
Complex Regional Pain Syndrome (CRPS) in children is often misdiagnosed due to lack of physician awareness. Early diagnosis and multidisciplinary treatment are crucial for managing this neuropathic pain condition in pediatric patients.
Area of Science:
- Neurology
- Pediatrics
- Pain Medicine
Context:
- Complex Regional Pain Syndrome (CRPS), also known as reflex dystrophy, is a neuropathic pain condition typically following limb trauma.
- Physician awareness of CRPS in children is limited, with infrequent mentions in pediatric literature and few published case reports.
- CRPS in pediatric populations often presents in older children and teenagers, predominantly affecting girls, with pain frequently localized to the leg.
Purpose:
- To highlight the under-recognition of Complex Regional Pain Syndrome (CRPS) in children among Danish physicians.
- To emphasize the diagnostic delays and treatment challenges associated with pediatric CRPS due to insufficient awareness.
- To advocate for early diagnosis and active, multidisciplinary management of CRPS in children.
Summary:
- CRPS in children is characterized by disproportionate pain intensity relative to trauma, extending beyond specific dermatomes.
- Delayed diagnosis is common because CRPS is not widely recognized or described in pediatric medical education.
- Treatment involves physiotherapy, pain management (including sympathetic nerve blocks and analgesics), and a multidisciplinary team approach.
Impact:
- Increased physician awareness can lead to earlier diagnosis and intervention for pediatric CRPS.
- Timely and active treatment, including multidisciplinary care, can significantly reduce the duration and severity of CRPS in children.
- Addressing the knowledge gap regarding CRPS in children is essential for improving patient outcomes and reducing the burden of this neuropathic pain condition.